-transparent.png){kind=logo}
The survival of patients with acute non-lymphoid leukaemias (ANLL) receiving chemotherapy (32 patients) or chemotherapy plus BCG (31 patients) has been compared in a randomized trial which started in Nov 1974. Fresh BCG (Institut Pasteur, Paris) was administered by Heaf gun in the interval of chemotherapy cycles. The overall survival was better in the chemo-immunotherapy group (median duration of survival of 25 months compared to 16 months in the chemotherapy group). However, the first remission duration did not differ (median duration of the 15 and 12 months, respectively). Plateau survival curves were not obtained in either group. A second complete remission was obtained in 7 out of 12 patients with bone marrow relapses in the chemo-immunotherapy group, and only in 2 out of 15 in the chemotherapy group (P less than 0.05). BCG seemed more efficient in patients older than 40 years; no difference was observed according to sex.
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
January 1980,
Sangre,
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
February 1994,
European journal of clinical investigation,
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
October 1980,
European journal of clinical investigation,
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
May 1976,
Lancet (London, England),
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
January 1976,
Journal of hygiene, epidemiology, microbiology, and immunology,
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
June 1987,
The Medical journal of Australia,
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
July 1975,
Minerva medica,
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
January 1987,
Haematologica,
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
January 1979,
Acta haematologica,
H Vuvan, and
D Fiere, and
M Doillon, and
C Martin, and
B Coiffier, and
P Felman, and
P A Bryon, and
J Favre-Gilly, and
L Revol
January 1986,
Virchows Archiv. B, Cell pathology including molecular pathology,
